All formulations and synthetic versions are included under the scheduled drugs list.
This bill would revise the schedule of controlled substances to add synthetic fentanyls, designer hallucinogenics, synthetic cannabinoids, system depressants, and other substances.
The bill would also change the list of schedule II drugs to include any material, compound, mixture, or preparation which contains any quantity of hydrocodone. Currently, this section only includes hydrocodone.
This bill would add depressants that include Ezogabine and Lacosamide to the schedule V list of controlled substances.
This bill was referred to the House Health Committee on 3.27.2017. This bill was heard in the House Health Committee on 4.5.2017.
Rep. Greg Murphy (R – Pitt) presented an amendment in the Committee to change the language on page 15 line 29 This amendment changed two chemical compounds that needed to be recategorized. The amendment passed unanimously.
This bill received a favorable report in the House Health Committee, and will now move to the House Judiciary I Committee.
This bill was heard in the House Judiciary I Committee on April 19, 2017. The bill received a favorable report, and will now move to the House floor.
This bill passed the House on April 20,2017 with a vote of 112-0. It will now move to the Senate.